Welcome to Hisun Pharmaceuticals USA
Hisun Pharmaceuticals USA, established in 2009, is an emerging pharmaceutical company committed to the development, manufacture and commercialization of pharmaceutical products for the US market place with a focus on APIs, Generics, Specialty and Animal Health Products. Hisun USA also provides contract manufacturing services through its parent company Zhejiang Hisun Pharmaceutical Co. Ltd.
Zhejiang Hisun Pharmaceutical Co. Ltd., established in 1956, is headquartered in Taizhou, China with more than 7,000 employees. Zhejiang Hisun Pharmaceutical Company is one of the largest Active Pharmaceutical Ingredient (API) manufacturers in China. Our API products are shipped to our partners throughout the world. Zhejiang Hisun Pharmaceutical also manufactures finished dosage pharmaceuticals – capsules, tablets and parenterals – for Anti-Infective, Cardiovascular, Oncology, CNS, Animal Health and other therapeutic areas. Zhejiang Hisun Pharmaceuticals also has Antibody Drug Conjugate (ADC) and biosimilar manufacturing facilities.
Hisun USA is well positioned for growth in the United States, supported by our state-of-the-art facilities, manufacturing expertise, research and development capabilities.
News & Events
- We've Moved! 02/08/ 2018
- Drug, Chemical & Associated Technologies Association (DCAT) Week 03/19/ 2018
- Convention of Pharmaceutical Ingredients (CPhI) North America 04/24/ 2018
- Hospital and Alternate Site Pharmacy EPPS 06/25/ 2018
- Specialty Pharmacy Summit 2018 04/29/ 2018
- CPhI China 05/14/ 2018
- ECRM 07/12/ 2018
- Pharma ChemOutsourcing 07/12/ 2018
- CPhI Worldwide 07/12/ 2018
- Retail Pharmacy – Generics EPPS 07/16/ 2018